- Report
- June 2024
- 137 Pages
Global
From €5302EUR$5,950USD£4,599GBP
- Report
- May 2024
- 137 Pages
United States
From €5302EUR$5,950USD£4,599GBP
- Report
- May 2024
- 133 Pages
Global
From €5791EUR$6,499USD£5,023GBP
- Report
- April 2024
- 137 Pages
Global
From €2672EUR$2,999USD£2,318GBP
- Report
- June 2025
- 250 Pages
Brazil
From €2485EUR$2,789USD£2,156GBP
- Report
- June 2025
- 250 Pages
India
From €2485EUR$2,789USD£2,156GBP
- Report
- June 2025
- 250 Pages
Mexico
From €2485EUR$2,789USD£2,156GBP
- Report
- June 2025
- 250 Pages
Japan
From €2485EUR$2,789USD£2,156GBP
- Report
- June 2024
- 200 Pages
Global
From €7084EUR$7,950USD£6,144GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4411EUR$4,950USD£3,826GBP
- Report
- January 2024
- 289 Pages
Global
From €6683EUR$7,500USD£5,796GBP
- Report
- November 2023
- 30 Pages
Global
From €2451EUR$2,750USD£2,125GBP
- Report
- November 2023
- 30 Pages
Global
From €2451EUR$2,750USD£2,125GBP
- Report
- January 2022
- 200 Pages
Global
From €6683EUR$7,500USD£5,796GBP
- Report
- August 2023
- 78 Pages
Canada
From €2651EUR$2,975USD£2,299GBP
€3119EUR$3,500USD£2,705GBP
- Report
- July 2024
- 101 Pages
Middle East, Africa
From €3074EUR$3,450USD£2,666GBP
- Report
- July 2024
- 108 Pages
Europe
From €3074EUR$3,450USD£2,666GBP
- Report
- July 2024
- 107 Pages
North America
From €3074EUR$3,450USD£2,666GBP
- Report
- February 2024
- 120 Pages
Global
From €4233EUR$4,750USD£3,671GBP
- Report
- May 2024
- 177 Pages
Global
From €2228EUR$2,500USD£1,932GBP

The Osteoarthritis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Osteoarthritis is a degenerative joint disease that affects millions of people worldwide. It is characterized by the breakdown of cartilage in the joints, leading to pain, stiffness, and decreased mobility. Treatment for osteoarthritis typically involves a combination of lifestyle changes, physical therapy, and medications. Common medications used to treat osteoarthritis include non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, and disease-modifying antirheumatic drugs (DMARDs).
The Osteoarthritis Drug market is highly competitive, with a variety of companies offering products to treat the condition. Some of the major players in the market include Pfizer, Merck, Novartis, AbbVie, and Johnson & Johnson. Other companies such as Amgen, Eli Lilly, and Bristol-Myers Squibb also offer products for the treatment of osteoarthritis. Show Less Read more